358 related articles for article (PubMed ID: 12134250)
1. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein.
Shimazaki T; Honda M; Kaneko S; Kobayashi K
Hepatology; 2002 Jan; 35(1):199-208. PubMed ID: 11786977
[TBL] [Abstract][Full Text] [Related]
3. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.
Krüger M; Beger C; Welch PJ; Barber JR; Manns MP; Wong-Staal F
Mol Cell Biol; 2001 Dec; 21(24):8357-64. PubMed ID: 11713272
[TBL] [Abstract][Full Text] [Related]
4. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
Pudi R; Ramamurthy SS; Das S
J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
[TBL] [Abstract][Full Text] [Related]
5. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
[TBL] [Abstract][Full Text] [Related]
6. Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells.
Kanda T; Yokosuka O; Imazeki F; Fujiwara K; Nagao K; Saisho H
Biochem Biophys Res Commun; 2005 Jun; 331(2):621-9. PubMed ID: 15850805
[TBL] [Abstract][Full Text] [Related]
7. Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses.
Dasgupta A; Das S; Izumi R; Venkatesan A; Barat B
FEMS Microbiol Lett; 2004 May; 234(2):189-99. PubMed ID: 15135522
[TBL] [Abstract][Full Text] [Related]
8. Correlation between translation efficiency and outcome of combination therapy in chronic hepatitis C genotype 3.
Yasmeen A; Hamid S; Granath FN; Lindström H; Elliott RM; Siddiqui AA; Persson MA
J Viral Hepat; 2006 Feb; 13(2):87-95. PubMed ID: 16436126
[TBL] [Abstract][Full Text] [Related]
9. Roles of the polypyrimidine tract and 3' noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation.
Wang H; Shen XT; Ye R; Lan SY; Xiang L; Yuan ZH
Arch Virol; 2005 Jun; 150(6):1085-99. PubMed ID: 15747050
[TBL] [Abstract][Full Text] [Related]
10. Riboproteomic analysis of polypeptides interacting with the internal ribosome-entry site element of foot-and-mouth disease viral RNA.
Pacheco A; Reigadas S; Martínez-Salas E
Proteomics; 2008 Nov; 8(22):4782-90. PubMed ID: 18937254
[TBL] [Abstract][Full Text] [Related]
11. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA.
Paek KY; Kim CS; Park SM; Kim JH; Jang SK
J Virol; 2008 Dec; 82(24):12082-93. PubMed ID: 18842733
[TBL] [Abstract][Full Text] [Related]
12. Cap and polyA tail enhance translation initiation at the hepatitis C virus internal ribosome entry site by a discontinuous scanning, or shunting, mechanism.
Wiklund L; Spångberg K; Goobar-Larsson L; Schwartz S
J Hum Virol; 2001; 4(2):74-84. PubMed ID: 11437317
[TBL] [Abstract][Full Text] [Related]
13. The hepatitis C virus internal ribosome-entry site: a new target for antiviral research.
Gallego J; Varani G
Biochem Soc Trans; 2002 Apr; 30(2):140-5. PubMed ID: 12023841
[TBL] [Abstract][Full Text] [Related]
14. Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation.
Panigrahi R; Hazari S; Chandra S; Chandra PK; Datta S; Kurt R; Cameron CE; Huang Z; Zhang H; Garry RF; Balart LA; Dash S
PLoS One; 2013; 8(8):e72791. PubMed ID: 24009705
[TBL] [Abstract][Full Text] [Related]
15. A mutational shift from domain III to II in the internal ribosome entry site of hepatitis C virus after interferon-ribavirin therapy.
Ogata K; Kashiwagi T; Iwahashi J; Hara K; Honda H; Ide T; Kumashiro R; Kohara M; Sata M; Watanabe H; Hamada N
Arch Virol; 2008; 153(8):1575-9. PubMed ID: 18592133
[TBL] [Abstract][Full Text] [Related]
16. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels.
Yamamoto C; Enomoto N; Kurosaki M; Yu SH; Tazawa J; Izumi N; Marumo F; Sato C
Hepatology; 1997 Dec; 26(6):1616-20. PubMed ID: 9398006
[TBL] [Abstract][Full Text] [Related]
18. hnRNP L is required for the translation mediated by HCV IRES.
Hwang B; Lim JH; Hahm B; Jang SK; Lee SW
Biochem Biophys Res Commun; 2009 Jan; 378(3):584-8. PubMed ID: 19061868
[TBL] [Abstract][Full Text] [Related]
19. Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES.
Kikuchi K; Umehara T; Nishikawa F; Fukuda K; Hasegawa T; Nishikawa S
Biochem Biophys Res Commun; 2009 Aug; 386(1):118-23. PubMed ID: 19501043
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein.
Shimoike T; Koyama C; Murakami K; Suzuki R; Matsuura Y; Miyamura T; Suzuki T
Virology; 2006 Feb; 345(2):434-45. PubMed ID: 16297950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]